ALYREF and hepatocellular carcinoma: Our findings were consistent with these reports: high expression levels of MCM10, CDKN3, RRM2, KIF3A, and ALYREF were correlated with poor prognosis, whereas elevated expression of CPEB2, COLEC10, and PBLD was associated with better prognosis in HCC patients.